Skip to main content
TipRanks
Go Ultimate75% OFF

Lexicon Pharmaceuticals (LXRX) Stock Statistics & Valuation Metrics

1,837 Followers

Total Valuation

Lexicon Pharmaceuticals has a market cap or net worth of $796.97M. The enterprise value is $710.63M.

Market Cap
$796.97M
Enterprise Value
$710.63M

Share Statistics

Lexicon Pharmaceuticals has 445,234,560 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
445,234,560
Owned by Insiders
61.21%
Owned by Institutions
19.13%

Financial Efficiency

Lexicon Pharmaceuticals’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -28.71%.

Return on Equity (ROE)
-0.47
Return on Assets (ROA)
-0.27
Return on Invested Capital (ROIC)
-28.71%
Return on Capital Employed (ROCE)
-0.30
Revenue Per Employee
614.85K
Profits Per Employee
-621.49K
Employee Count
81
Asset Turnover
0.27
Inventory Turnover
0.98

Valuation Ratios

The current PE Ratio of Lexicon Pharmaceuticals is -12.32. Lexicon Pharmaceuticals’s PEG ratio is 0.10.

PE Ratio
-12.32
PS Ratio
20.68
PB Ratio
4.86
Price to FCF
-12.46
Price to Operating Cash Flow
-12.45
PEG Ratio
0.10

Income Statement

In the last 12 months, Lexicon Pharmaceuticals had revenue of 49.80M and earned -50.34M in profits. Earnings per share was -0.14.

Revenue
49.80M
Gross Profit
49.53M
Operating Income
-48.91M
Pretax Income
-50.34M
Net Income
-50.34M
EBITDA
-41.38M
Earnings Per Share (EPS)
-0.14

Cash Flow

In the last 12 months, operating cash flow was -63.96M and capital expenditures 0, giving a free cash flow of -63.96M billion.

Operating Cash Flow
-63.96M
Free Cash Flow
-63.96M
Free Cash Flow per Share
-0.14

Dividends & Yields

Lexicon Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-8.03%
Earnings Yield
-7.83%

Stock Price Statistics

Beta
1.45
52-Week Price Change
24.31%
50-Day Moving Average
1.78
200-Day Moving Average
1.90
Relative Strength Index (RSI)
58.30
Average Volume (3m)
2.63M

Important Dates

Lexicon Pharmaceuticals upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Mar 11, 2027
Ex-Dividend Date
―

Financial Position

Lexicon Pharmaceuticals as a current ratio of 4.88, with Debt / Equity ratio of 57.87%

Current Ratio
4.88
Quick Ratio
4.87
Debt to Market Cap
0.13
Net Debt to EBITDA
-0.67
Interest Coverage Ratio
-5.87

Taxes

In the past 12 months, Lexicon Pharmaceuticals has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Lexicon Pharmaceuticals EV to EBITDA ratio is -14.46, with an EV/FCF ratio of -12.70.

EV to Sales
21.08
EV to EBITDA
-14.46
EV to Free Cash Flow
-12.70
EV to Operating Cash Flow
-12.70

Balance Sheet

Lexicon Pharmaceuticals has $183.20M in cash and marketable securities with $59.54M in debt, giving a net cash position of $123.67M billion.

Cash & Marketable Securities
$183.20M
Total Debt
$59.54M
Net Cash
$123.67M
Net Cash Per Share
$0.28
Tangible Book Value Per Share
$0.27

Margins

Gross margin is 98.59%, with operating margin of -147.42%, and net profit margin of -161.80%.

Gross Margin
98.59%
Operating Margin
-147.42%
Pretax Margin
-161.80%
Net Profit Margin
-161.80%
EBITDA Margin
-145.80%
EBIT Margin
-146.91%

Analyst Forecast

The average price target for Lexicon Pharmaceuticals is $5.85, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$5.85
Price Target Upside
226.82% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
-45.62%
EPS Growth Forecast
21.16%

Scores

Smart Score
10
AI Score
49